Invention Grant
- Patent Title: Selective cell therapy for the treatment of renal failure
- Patent Title (中): 选择性细胞治疗肾衰竭治疗
-
Application No.: US14856043Application Date: 2015-09-16
-
Publication No.: US09534203B2Publication Date: 2017-01-03
- Inventor: Anthony Atala , James J. Yoo
- Applicant: Wake Forest University Health Sciences
- Applicant Address: US NC Winston-Salem
- Assignee: Wake Forest University Health Sciences
- Current Assignee: Wake Forest University Health Sciences
- Current Assignee Address: US NC Winston-Salem
- Agency: Myers Bigel, P.A.
- Main IPC: C12N5/00
- IPC: C12N5/00 ; A01N63/00 ; A61F13/00 ; A61K9/14 ; A01N65/00 ; C12N5/071 ; A61K35/22 ; A61K9/00 ; G01N15/10 ; G01N33/569 ; A61K35/12 ; G01N15/00

Abstract:
Provided herein are isolated populations of kidney cells harvested from differentiated cells of the kidney, wherein cells have been expanded in vitro. The kidney cells may include peritubular interstitial cells of the kidney, and preferably produce erythropoietin (EPO). The kidney cells may also be selected based upon EPO production. Methods of producing an isolated population of EPO producing cells are also provided, and methods of treating a kidney disease resulting in decreased EPO production in a patient in need thereof are provided, including administering the population to the patient, whereby the cells produce EPO in vivo.
Public/Granted literature
- US20160002603A1 SELECTIVE CELL THERAPY FOR THE TREATMENT OF RENAL FAILURE Public/Granted day:2016-01-07
Information query